JP2023538594A5 - - Google Patents
Info
- Publication number
- JP2023538594A5 JP2023538594A5 JP2023512073A JP2023512073A JP2023538594A5 JP 2023538594 A5 JP2023538594 A5 JP 2023538594A5 JP 2023512073 A JP2023512073 A JP 2023512073A JP 2023512073 A JP2023512073 A JP 2023512073A JP 2023538594 A5 JP2023538594 A5 JP 2023538594A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- hydrogen
- formula
- alkyl
- diastereomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026062962A JP2026117077A (ja) | 2020-08-19 | 2026-04-07 | 選択されたプリンホスホルアミデートの立体選択的製造 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063067726P | 2020-08-19 | 2020-08-19 | |
| US63/067,726 | 2020-08-19 | ||
| US202063074302P | 2020-09-03 | 2020-09-03 | |
| US63/074,302 | 2020-09-03 | ||
| US202063094759P | 2020-10-21 | 2020-10-21 | |
| US63/094,759 | 2020-10-21 | ||
| US202063129306P | 2020-12-22 | 2020-12-22 | |
| US63/129,306 | 2020-12-22 | ||
| PCT/US2021/046778 WO2022040473A1 (en) | 2020-08-19 | 2021-08-19 | Stereoselective manufacture of selected purine phosphoramidates |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026062962A Division JP2026117077A (ja) | 2020-08-19 | 2026-04-07 | 選択されたプリンホスホルアミデートの立体選択的製造 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023538594A JP2023538594A (ja) | 2023-09-08 |
| JP2023538594A5 true JP2023538594A5 (cg-RX-API-DMAC7.html) | 2024-08-27 |
| JP7851034B2 JP7851034B2 (ja) | 2026-04-24 |
Family
ID=80323295
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023512073A Active JP7851034B2 (ja) | 2020-08-19 | 2021-08-19 | 選択されたプリンホスホルアミデートの立体選択的製造 |
| JP2026062962A Pending JP2026117077A (ja) | 2020-08-19 | 2026-04-07 | 選択されたプリンホスホルアミデートの立体選択的製造 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026062962A Pending JP2026117077A (ja) | 2020-08-19 | 2026-04-07 | 選択されたプリンホスホルアミデートの立体選択的製造 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230331751A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4200309A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7851034B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230053640A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115884977A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021327241A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3173661A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023002064A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022040473A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115477679A (zh) | 2017-02-01 | 2022-12-16 | 阿堤亚制药公司 | 用于治疗丙型肝炎病毒的核苷酸半硫酸盐 |
| US10874687B1 (en) | 2020-02-27 | 2020-12-29 | Atea Pharmaceuticals, Inc. | Highly active compounds against COVID-19 |
| AU2022291927A1 (en) | 2021-06-17 | 2024-01-04 | Atea Pharmaceuticals, Inc. | Advantageous anti-hcv combination therapy |
| CN116462728B (zh) * | 2021-12-15 | 2023-12-12 | 南京知和医药科技有限公司 | 一种抗病毒感染的嘌呤核苷衍生物及其药物组合物和用途 |
| US12065404B2 (en) | 2022-03-18 | 2024-08-20 | Enveric Biosciences Canada Inc. | C4-carboxylic acid-substituted tryptamine derivatives and methods of using |
| CN121628124B (zh) * | 2026-02-05 | 2026-04-10 | 山东鲁源化工科技有限公司 | 一种高热稳定性聚磷酸酯阻燃剂及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2870169A1 (en) * | 2012-07-03 | 2015-05-13 | Bristol-Myers Squibb Company | Process for preparing diastereomerically enriched phosphoramidate derivatives of nucleoside compounds for treatment of viral infections |
| FI3265102T3 (fi) * | 2015-03-06 | 2025-10-31 | Atea Pharmaceuticals Inc | Beta-d-2'-deoksi-2'-alfa-fluori-2'-beta-c-substituoituja-2-modifioituja-n6-substituoituja puriininukleotideja hcv-hoitoa varten |
| PT3512863T (pt) * | 2016-09-07 | 2022-03-09 | Atea Pharmaceuticals Inc | Nucleótidos de purina 2'-substituídos-n6-substituídos para tratamento de vírus de rna |
| US10874687B1 (en) * | 2020-02-27 | 2020-12-29 | Atea Pharmaceuticals, Inc. | Highly active compounds against COVID-19 |
| WO2021173713A1 (en) * | 2020-02-27 | 2021-09-02 | Atea Pharmaceuticals, Inc. | Highly active compounds against covid-19 |
-
2021
- 2021-08-19 WO PCT/US2021/046778 patent/WO2022040473A1/en not_active Ceased
- 2021-08-19 JP JP2023512073A patent/JP7851034B2/ja active Active
- 2021-08-19 AU AU2021327241A patent/AU2021327241A1/en active Pending
- 2021-08-19 EP EP21859165.9A patent/EP4200309A4/en active Pending
- 2021-08-19 CN CN202180051015.9A patent/CN115884977A/zh active Pending
- 2021-08-19 KR KR1020237008983A patent/KR20230053640A/ko active Pending
- 2021-08-19 CA CA3173661A patent/CA3173661A1/en active Pending
- 2021-08-19 MX MX2023002064A patent/MX2023002064A/es unknown
-
2023
- 2023-02-17 US US18/111,316 patent/US20230331751A1/en active Pending
-
2026
- 2026-04-07 JP JP2026062962A patent/JP2026117077A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024503855A (ja) | アミノピリミジン系ｆａｋ阻害剤化合物を合成する方法 | |
| ES2641761T3 (es) | Procedimientos para preparar inhibidores JAK y compuestos intermedios relacionados | |
| CN101541818A (zh) | 4’-叠氮基胞苷衍生物的制备方法 | |
| JP7851034B2 (ja) | 選択されたプリンホスホルアミデートの立体選択的製造 | |
| ES2738211T3 (es) | Procedimiento mejorado de preparación de profármacos a base de duocarmicina | |
| WO2018104953A1 (en) | Improved process for the preparation of 7-{4-[4-(2,3-dichlorophenyl)-piperazin-1-yl]butoxy}-2oxo-3,4-dihydro-2h-quinolin-1-yl)methyl dodecanoate | |
| JP2017057215A (ja) | ４−アミノ−５−ビフェニル−４−イル−２−ヒドロキシメチル−２−メチル−ペンタン酸化合物を調製する方法 | |
| EP3411359B1 (en) | Methods of preparing hydroxylamine derivatives useful in the preparation of anti-infective agents | |
| EP1904489B1 (en) | Process for the synthesis of triazoles | |
| KR20100102107A (ko) | β-뉴클레오시드의 새로운 합성 방법 | |
| TWI887245B (zh) | 用於產生二氮雜螺內醯胺化合物之方法及中間物 | |
| EP3515915B1 (en) | Process for preparing beta-lactamase inhibitor hydroxylurea intermediates | |
| WO2011156355A1 (en) | Production method of phenyl guanidine salts and their intermediates | |
| KR102899410B1 (ko) | 가교형 뉴클레오시드 중간체의 결정 및 그의 제조 방법, 그리고 가교형 뉴클레오시드 아미다이트의 제조 방법 | |
| CN113166184B (zh) | 用于制备环状二核苷酸的方法 | |
| JP2023517735A (ja) | オキシム中間体及び関連化合物を介した３’ｎヌクレオシドの合成 | |
| CN102924454B (zh) | 恩替卡韦的合成方法 | |
| ES2314449T3 (es) | Derivados de peptidil cetona heterociclicos y procedimiento de preparacion. | |
| WO2017134607A1 (en) | A process for the preparation of phosphatidylinositol 3-kinase inhibitor | |
| JP4181233B2 (ja) | ピロリジン−２，４−ジオン誘導体の製法 | |
| HK40120549A (en) | Processes and intermediates for producing diazaspiro lactam compounds | |
| KR20250121547A (ko) | 핵산 합성용 링커, 및 담체, 그리고 그들의 제조방법 | |
| JP2022035954A (ja) | Ｎ－Ｂｏｃ－ラクタム誘導体及びその製造方法、並びに、環状アミン誘導体の製造方法 | |
| JP6040250B2 (ja) | ２−［（２ｅ）−２−フルオロ−２−（３−ピペリジニリデン）エチル］−１ｈ−イソインドール−１，３（２ｈ）−ジオンを調製するための改良された方法 | |
| JPWO2009107692A1 (ja) | ２’−水酸基が保護されたリボヌクレオシド誘導体およびその製造方法 |